id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2023-0095-0001,DEA,DEA-2023-0095,Importer of Controlled Substances Application Aurobindo Pharma USA Inc. - DEA1225,Notice,,2023-07-12T04:00:00Z,2023,7,2023-07-12T04:00:00Z,2023-08-12T03:59:59Z,2023-07-12T12:17:43Z,2023-14759,0,0,0900006485c8b53b